-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1516-p003-ef.pdf
March 01, 2016 - (primarily smoking) often continues into adulthood, leading to serious and costly diseases
such as lung
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/references/meta/meta-analyses-refs.pdf
January 01, 2007 - Heart Lung 1983;12(1):65-73.
Slama K, Redman S, Perkins J, et al. … Heart Lung 1983;12(1):65-73.
Stevens VJ, Severson H, Lichtenstein E, et al. … Heart Lung 1983;12(1):65-73.
Slama K, Redman S, Perkins J, et al. … Heart Lung 1983;12(1):65-73.
Slama K, Redman S, Perkins J, et al. … Heart Lung 1983;12(1):65-73.
Slama K, Redman S, Perkins J, et al.
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-2-tech-specs.pdf
February 09, 2018 - temperature gap > 3°C
Respiratory
• PaO2/FIO2 < 300 in absence of cyanotic heart disease or preexisting lung
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-1-tables-1-4.pdf
June 15, 2018 - temperature gap > 3°C
Respiratory
PaO2/FIO2 < 300 in absence of cyanotic heart disease or preexisting lung
-
www.healthcare411.ahrq.gov/research/findings/evidence-based-reports/search.html?page=6
November 01, 2020 - Infectious Diseases
(55)
Kidney and Urological Conditions
(28)
Laboratory Testing
(17)
Lung
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/professionals/education/curriculum-tools/shareddecisionmaking/success-stories/share_approach_success_story5_anthem-patel.pdf
May 01, 2016 - decisionmaking requirements—including the use of a decision aid— for reimbursement for
the screening for lung
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-sepsis-antibiotics-technical-specs.pdf
August 01, 2014 - temperature gap > 3°C
Respiratory
• PaO2/FIO2 < 300 in absence of cyanotic heart disease or preexisting lung
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-tech-specs.pdf
June 15, 2018 - gap > 3°C
Respiratory
• PaO2/FIO2 < 300 in absence of cyanotic heart disease or preexisting
lung
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0217-section-5-table-5.pdf
April 01, 2014 - III National Heart Lung and Blood
Institute. The Management of Sickle
Cell Disease.
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chirpa-215-scd-ed-tables.pdf
January 01, 2002 - III National Heart, Lung,
and Blood Institute. The
Management of Sickle
Cell Disease.
-
www.healthcare411.ahrq.gov/research/findings/evidence-based-reports/search.html
April 01, 2024 - Infectious Diseases
(55)
Kidney and Urological Conditions
(28)
Laboratory Testing
(17)
Lung
-
www.healthcare411.ahrq.gov/research/findings/evidence-based-reports/search.html?page=1
November 01, 2023 - Infectious Diseases
(55)
Kidney and Urological Conditions
(28)
Laboratory Testing
(17)
Lung
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-213-section-5-table-4.pdf
January 01, 2012 - III National Heart Lung and
Blood Institute. The
Management of Sickle
Cell Disease.
-
www.healthcare411.ahrq.gov/news/newsletters/e-newsletter/896.html
January 01, 2024 - Methods for using race and ethnicity in prediction models for lung cancer screening eligibility.
-
www.healthcare411.ahrq.gov/evidencenow/projects/heart-health/evidence/cholesterol.html
March 01, 2021 - The guideline was the result of a collaboration with the National Heart, Lung, and Blood Institute (NHLBI
-
www.healthcare411.ahrq.gov/cahps/quality-improvement/improvement-guide/6-strategies-for-improving/health-promotion-education/strategy6j-support-self-care.html
March 01, 2020 - health outcomes. 5
Studies of support groups formed for chronic arthritis, heart disease, stroke, and lung
-
www.healthcare411.ahrq.gov/research/findings/studies/index.html
January 01, 2024 - Breast Cancer
(197)
Cancer: Cervical Cancer
(21)
Cancer: Colorectal Cancer
(116)
Cancer: Lung … Minorities, Policy
Steuart R , Pan AY , Woolums A Respiratory culture growth and 3-years lung … Respiratory culture growth and 3-years lung health outcomes in children with bronchopulmonary dysplasia
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-135-fullreport.pdf
February 01, 2017 - The National Heart, Lung and Blood Institute (NHLBI) estimates that 2,000 infants
are born with SCD … National Heart Lung and Blood Institute. The Management of Sickle Cell Disease. … serious infection (Gaston, Verter, Woods, et al., 1986;
Hirst, Owusu-Ofori, 2010; National Heart, Lung … Cochrane Database of Systematic Reviews. 2010; 1-21.
9
National Heart, Lung and Blood Institute
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/outcomes/chipra-81-pgh-7-notes-citations.pdf
October 09, 2018 - National Heart, Lung, and Blood Institute.
-
www.healthcare411.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-136-fullreport.pdf
July 01, 2018 - 2009; Leickly, Wade, Crain, et al., 1998; Lozano, Finkelstein, Carey, et al., 2004;
National Heart, Lung … Nurs
Times 2009; 105(4):22-3.
31
American Lung Association. … Available at
http://www.lung.org/lung-health-and-diseases/lung-disease-lookup/asthma/learn-about-
asthma … Salmeterol/fluticasone propionate vs. double dose
fluticasone propionate on lung function and asthma … National Heart, Lung, and Blood Institute (NHLBI).